Jury Hits Natera With $45M Verdict In CareDx False Ad Suit
A Delaware federal jury on Monday awarded CareDx $44.9 million after finding that rival medical test company Natera Inc. falsely advertised its kidney transplant rejection test as superior to CareDx's competing...To view the full article, register now.
Already a subscriber? Click here to view full article